$Esperion Therapeutics (ESPR.US)$Esperion initiated with an Overweight at Cantor Fitzgerald - TipRanks.com BELOW is a Detailed research report that should convince readers to have a portion of their investment portfolio in Esperion. This is not a pump article, please take the time to read and fact check. This $2 stock will be $20+ by 2027. Esperion anticipates billions in Revenues. Es...
Esperion Therapeutics股票讨论
Es...
让我们把它推到月球上,伙计们!
但为什么???认真的。。。
暂无评论